WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

A SYSTEMIC REVIEW OF DUSHTA PRATISHYAYA W.S.R TO CHRONIC SINUSITIS

Amisha Patel* and Dr. D. B. Vaghela

Abstract

Dushta Pratishyaya (Chronic Sinusitis) is a common clinical ailed in ENT clinics specially in dusty, smoky, humid, costal area. Five types of Partishyaya on the basis of vitiation of Dosha are describe in Ayurvedic classics. Vata is the chief culprit and other Dosha are associated with it. Dushta Pratishyaya is considered as the complication of all types of Pratishyaya. Generally, Dushta Pratishyaya is said to be similar to Chronic sinusitis in modern science. It's prevalence is almost 15% in all over world. There are many research works carried out on it. Present study is aimed to review clinical research works which were carried out on Dushta Pratishyaya in Shalakya Tantra Department of IPGT and RA, GAU, Jamnagar. In these studies Varunadi Ghrita and Anu Taila Nasya, Trayodhashanga Kwatha and Pradhamana Nasya of Trikatu and Triphala Churna, Vyaghri Haritaki Avaleha and Anu Taila Nasya were used as treatment. Overall effect of therapy of these study drugs on the disease showed highly significant results in relieving the signs and symptoms of this disease.

Keywords: Chronic Sinusitis, Dushta Pratishyaya, Nasya, Vyaghri Haritaki Avaleha.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More